Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-04-12 4:24 pm Sale | 13D | CARTESIAN THERAPEUTICS, INC. C RNAC | SPRINGER TIMOTHY A | 6,473,184 36.4% | -187,716,129 (-96.67%) | View |
2024-04-10 4:29 pm Sale | 13D | CARTESIAN THERAPEUTICS, INC. C RNAC | Kalayoglu Murat | 3,538,386 19.9% | -35,806,077 (-91.01%) | View |
2024-04-10 4:25 pm Sale | 13D | CARTESIAN THERAPEUTICS, INC. C RNAC | Singer Michael | 769,744 4.3% | -25,291,183 (-97.05%) | View |
2024-03-28 5:27 pm Purchase | 13D | CARTESIAN THERAPEUTICS, INC. C RNAC | SPRINGER TIMOTHY A | 194,189,313 27.9% | 1,248,649 (+0.65%) | View |
2024-03-11 08:19 am Purchase | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | FMR LLC | 16,869,200 10.417% | 3,612,826 (+27.25%) | View |
2024-02-14 12:38 pm Sale | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | MANGROVE PARTNERS IM LLC | 4,127,258 2.59% | -5,260,419 (-56.04%) | View |
2024-02-09 5:13 pm Purchase | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | Artal International S.C.A. | 10,455,849 6.4% | 248,859 (+2.44%) | View |
2024-02-09 08:50 am Purchase | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | FMR LLC | 13,256,374 8.186% | 13,256,374 (New Position) | View |
2023-11-22 4:39 pm Purchase | 13D | CARTESIAN THERAPEUTICS, INC. C RNAC | Singer Michael | 26,060,927 13.9% | 26,060,927 (New Position) | View |
2023-11-22 4:38 pm Purchase | 13D | CARTESIAN THERAPEUTICS, INC. C RNAC | Kalayoglu Murat | 39,344,463 19.9% | 39,344,463 (New Position) | View |
2023-11-17 08:15 am Purchase | 13D | CARTESIAN THERAPEUTICS, INC. C RNAC | SPRINGER TIMOTHY A | 192,940,664 27.7% | 148,584,078 (+334.98%) | View |
2023-09-22 7:31 pm Purchase | 13D | CARTESIAN THERAPEUTICS, INC. C RNAC | SPRINGER TIMOTHY A | 44,356,586 28.9% | 11,693,670 (+35.80%) | View |
2023-06-12 4:30 pm Purchase | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | Artal International S.C.A. | 10,206,990 6.6% | 10,206,990 (New Position) | View |
2023-02-14 1:45 pm Purchase | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | MANGROVE PARTNERS IM LLC | 9,387,677 5.97% | 1,011,770 (+12.08%) | View |
2022-07-27 4:37 pm Purchase | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | MANGROVE PARTNERS IM LLC | 8,375,907 5.37% | 375,000 (+4.69%) | View |
2022-05-23 5:39 pm Purchase | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | MANGROVE PARTNERS IM LLC | 8,000,907 5.14% | 119,133 (+1.51%) | View |
2022-05-09 3:23 pm Sale | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | BlackRock Inc. BLK | 6,806,285 4.5% | -145,597 (-2.09%) | View |
2022-02-14 1:18 pm Sale | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | BIOTECHNOLOGY VALUE FUND L P | 1,723,133 1.5% | -3,202,975 (-65.02%) | View |
2022-02-02 7:11 pm Purchase | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | BlackRock Inc. BLK | 6,951,882 6% | 1,477,558 (+26.99%) | View |
2021-12-27 4:05 pm Purchase | 13D | CARTESIAN THERAPEUTICS, INC. C RNAC | SPRINGER TIMOTHY A | 32,662,916 28% | 211,190 (+0.65%) | View |